Harnessing TP73?targeted nintedanib: A novel strategy to halt triple?negative breast cancer via p53?PPARalpha/PI3K?Akt pathway suppression. Zou X, Li S, Huang S, Niu R, et al. Int J Oncol 2025;67:88.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zou X, Li S, Huang S, Niu R, et al. Harnessing TP73?targeted nintedanib: A novel strategy to halt triple?negative breast cancer via p53?PPARalpha/PI3K?Akt pathway suppression. Int J Oncol 2025;67:88.
PMID: 40849803